Faiez Al Nimer Selected Research

Peptides (Polypeptides)

1/2021

Cerebrospinal fluid brevican and neurocan fragment patterns in human traumatic brain injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Faiez Al Nimer Research Topics

Disease

13	Multiple Sclerosis 03/2024 - 01/2013
8	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2021 - 01/2013
4	Autoimmune Diseases (Autoimmune Disease) 03/2024 - 01/2018
3	Relapsing-Remitting Multiple Sclerosis 01/2023 - 12/2019
3	Inflammation (Inflammations) 12/2014 - 04/2012
2	Infections 01/2023 - 01/2013
2	Wounds and Injuries (Trauma) 12/2021 - 05/2013
2	Normal Pressure Hydrocephalus 01/2021 - 10/2020
2	Brain Injuries (Brain Injury) 01/2021 - 06/2006
2	Central Nervous System Diseases (CNS Diseases) 01/2015 - 02/2014
1	Rubella (German Measles) 03/2024
1	Bacterial Infections (Bacterial Infection) 03/2024
1	Measles 03/2024
1	Neuroinflammatory Diseases 12/2021
1	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 02/2019
1	Disease Progression 02/2019
1	Encephalitis (Encephalitis, Rasmussen) 01/2018
1	Fatigue 01/2018
1	Neuralgia (Stump Neuralgia) 12/2014
1	Peripheral Nerve Injuries 12/2014
1	Brain Contusion 08/2004

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2013
3	Rituximab (Mabthera)FDA Link 01/2023 - 01/2020
3	Complement System Proteins (Complement)IBA 01/2015 - 01/2013
2	AntigensIBA 03/2024 - 08/2004
2	Proteins (Proteins, Gene)FDA Link 12/2021 - 10/2019
2	Dimethyl FumarateIBA 01/2020 - 12/2019
2	C-Type Lectins (C-Type Lectin)IBA 12/2014 - 05/2013
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 06/2006 - 08/2004
1	Immunoglobulin G (IgG)IBA 03/2024
1	B-Cell Activating FactorIBA 12/2023
1	COVID-19 VaccinesIBA 11/2022
1	AutoantigensIBA 04/2022
1	ApolipoproteinsIBA 12/2021
1	Serum AlbuminIBA 12/2021
1	Immunomodulating AgentsIBA 09/2021
1	AutoantibodiesIBA 01/2021
1	BrevicanIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Proteoglycans (Proteoglycan)IBA 01/2021
1	Small Untranslated RNAIBA 01/2021
1	NeurocanIBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 10/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Blood Proteins (Serum Proteins)IBA 10/2019
1	HLA-DR15 antigenIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	CytokinesIBA 01/2018
1	Interleukin-8 (Interleukin 8)IBA 01/2018
1	Lipocalin-2IBA 02/2016
1	Complement 3d Receptors (Complement Receptor 2)IBA 01/2016
1	ButyrylcholinesteraseIBA 01/2015
1	Glutathione Transferase (Glutathione S-Transferase)IBA 03/2013
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2013
1	CXC ChemokinesIBA 01/2013
1	OsteopontinIBA 01/2013
1	LigandsIBA 01/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2012

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2018
1	Duration of Therapy 11/2022
1	Critical Care (Surgical Intensive Care) 02/2019
1	Ligation 12/2014
1	Transplantation 06/2006